Homeright arrow
Resource & Webinar: "Kratom and Its Alkaloids: A Balanced Review of the Science and State Regulation"

Resource & Webinar: "Kratom and Its Alkaloids: A Balanced Review of the Science and State Regulation"

Check mark
Media
|
date
November 19, 2026
|

The Reason Foundation has recently released "Kratom and Its Alkaloids: A Balanced Review of the Science and State Regulation," a monograph that is an excellent source about this plant-based product, which people have used for centuries to treat pain and anxiety disorders. It provides detailed information on the pharmacology, drug interactions, addictive potential, overdose potential, epidemiology, and sociology of these products, which are increasingly popular in Western countries. The timing of this monograph is important, as the DEA has recently announced its intent to place the semi-synthetic 7-OH (the most active constituent of kratom) in Schedule 1. Kratom, however, will not be scheduled.

This link will take you to a summary of the monograph. The site also includes a webinar recorded with the lead author, Michelle Minton, addiction psychiatrist; Jeff Singer, MD, from the Reason Foundation and D4DPR expert; Bryon Adinoff, MD, president of Doctors for Drug Policy Reform; and two patients who regularly use and benefit from kratom and 7-OH. Beneath the webinar video, you can read or download the PDF version of the monograph.

The Reason Foundation has crafted model state legislation for state lawmakers, accessible here: https://reason.org/wp-content/uploads/model-legislation-kratom-product-regulation.pdf

Share:

About the Author